Health Research Grants Head Behind Closed Doors for Review
Published Date: 10/21/2026
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in November 2026 to review important grant applications related to health research. These meetings protect private info and trade secrets while deciding which projects get funding. Scientists and small businesses applying for grants will be affected, with no changes to timing or money announced.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Closed reviews protect trade secrets
If you submitted one of the listed NIH grant applications, your application will be reviewed in meetings closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) because discussions could disclose confidential trade secrets, commercial property (such as patentable material), or personal information. Those closed virtual meetings occur on the dates listed in November 2026 (for example, November 16–19, 2026 for various panels).
NIH peer-review panels scheduled in November 2026
The NIH Center for Scientific Review will hold virtual panels in November 2026 to review and evaluate grant applications for named programs. Examples of scheduled reviews and dates include PAR-24-272: CTSA Program (November 16–17, 2026); Mechanisms of Cancer Therapeutics (November 17–18, 2026); Small Business: Advanced Therapeutics (November 17, 2026); Small Business: Cancer Immunotherapy Development (November 18–19, 2026); RFA-RM-26-017 R03 Pilot Projects (November 18–19, 2026); plus multiple fellowship, training, and disease-focused study sections on November 17–18, 2026.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-21527, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in November 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for scientific projects, especially in biophysics, immunology, neurodegenerative disorders, and anti-infective therapies. No public access is allowed to protect private and sensitive information, but these reviews help decide who gets research money.
2026-21526, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in November 2026 to review and decide on grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for important health research. If you’re involved in health or small business research grants, these reviews could impact your funding timeline and opportunities.
2026-21395, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in November 2026 to review grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists applying for grants and small businesses in health research should note these important review dates.
2026-21022, Center For Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in November 2026 to review and decide on grant applications related to cancer, chemistry, kidney health, and small business health projects. These meetings protect private info and trade secrets while helping decide who gets research funding. Scientists and small businesses applying for grants should note these dates for their funding chances.
2026-20771, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in early November 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers seeking funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-20705, Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof
The National Institute of Allergy and Infectious Diseases plans to give Korea National Institute of Health an exclusive license to develop and sell a special antibody that targets a dangerous virus causing severe fever and low platelets. This deal helps speed up turning the invention into real-world treatments. Comments or license requests must be sent by October 26, 2026.
Previous / Next Documents
Previous: 2026-21524, No Adjustment to HHS Civil Monetary Penalty Amounts for 2026
Good news for folks dealing with HHS fines: the penalty amounts won’t go up in 2026. HHS is sticking with the 2025 penalty levels because there’s no cost-of-living increase this year. This means no surprise hikes for anyone facing civil monetary penalties under HHS rules starting October 21, 2026.
Next: 2026-21526, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in November 2026 to review and decide on grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for important health research. If you’re involved in health or small business research grants, these reviews could impact your funding timeline and opportunities.